A cell membrane-hybridized nanocarrier-based RNA delivery system for ocular neovascular diseases

An endothelial cell membrane-hybridized lipid nanoparticle is developed that achieve specific targeting of neovascular endothelial cells through “homing effects”, providing a safe and effective delivery strategy for RNA therapy of ocular neovascular diseases.